Vericel Profile

USD 0.15  3.19%
4.05Last Month High 5.1 
4.65Trading Day  High 4.9 

Vericel exotic insider transaction detected

Vericel Corporation insider trading alert for general transaction of stock option (right to buy) by Bartel Ronnda, Chief Scientific Officer, on August 29, 2017. This event was filed by Vericel Corp with SEC on 2010-09-03. Initial filing of beneficial ownership - SEC Form 3 [view details]   

Vericel Summary

Vericel Corporation (VCEL) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 190 people. Vericel Corporation was previously listed under the symbol ASTM. Vericel is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 169.3 M. Vericel Corporation has 34.91 M outstanding shares of which 1.28 M shares are at this time shorted by private and institutional investors with about 2.4 trading days to cover. Vericel Corporati currently holds about 15.47 M in cash with (23.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check Vericel Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Consonance Capital Management LpCommon Shares3 M18.1 M
Archon Capital Management LlcCommon Shares2.6 M15.7 M
View Vericel Diagnostics

Selected Vericel Corporation Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Vericel Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 63% 
Vericel Corporationration, a commercialstage biopharmaceutical company, researches, develops, manufactures, markets, and sells patientspecific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameVericel Corporation
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressCambridge, MA
ExchangeNasdaq Capital Markets
Prior SymbolASTM
IndustryPharmaceutical Products
Contact Number617 588 5555
Related EntityASTM
CurrencyUSD - US Dollar


Vericel Analyst Recommendations
Target PriceAdvice# of Analysts
Vericel Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Vericel Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Vericel Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.22March 13, 2017
Vericel Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate